Sandra Stein, MD, of Banner Health Plans, details how she provides clinical and medical leadership in her role as chief medical officer.
Sandra Stein, MD, of Banner Health Plans, summarized her responsibilities as chief medical officer. She explained that, within her role, she focuses on member experience and providing high-quality care while taking into account behavioral health, social determinants of health, physical health, and health equity.
Stein was a part of the panel discussion at The American Journal of Managed Care®’s Institute for Value-Based Medicine® (IVBM) event held in partnership with Banner|Aetna on December 12, 2023. The discussion centered around a commentary published in JAMA Network titled "Health Systems and Social Services—A Bridge Too Far?" which stated that health systems should not invest in social determinants of health.
Transcript
Could you please explain your responsibilities in your role of chief medical officer for Banner Health Plans?
We [Banner Health Plans] see ourselves as a community leader as a safety net health system. As my role, I provide clinical and medical leadership and, really, a multi-pronged, very broad strategy. As we're very focused in the community, we look at making sure we provide integrated and innovative care. Our integrated lens is very broad; we think about behavioral health, physical health, social determinants of health, and health equity that are absolutely critical.
My key areas end up looking at the utilization management of care, which really looks at, basically, the right services, at the right place, at the right time for our members or patients. Also, the highest quality of care, so we're ensuring that our members are getting evidence-based services and that they have quick access to those services because, certainly, there are issues with the capacity within the system.
We want to make sure member experience is as easy as possible. We all know that health care can be hard, and our mission is making health care easier so life can be better. That's one of my key focuses, and we certainly want to make sure that our providers are doing just that, focused on providing care and reducing that burden associated with provision of care.
In addition to that, we really want to focus on keeping our members as well as possible. How do we provide education? How do we support nutrition? How do we support relaxation? Exercise, innovation, technology, are absolutely critical. We learned about that during COVID; health care will never be the same, really leveraging traditional services with technology and other forms of innovative in-home care.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
2 Commerce Drive
Cranbury, NJ 08512